is part of the Informa Markets Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Classifying certain professions as "systemically relevant" is easy. Actually, protecting them effectively against imminent infections is much more challenging. The trade and public authorities still too seldom rely on technical protective equipment that has long been available
In terms of hygiene, there are enormous differences between the hospitals of the world. Although there are differences between EU countries, compared to African standards there is still a huge quality gap in the handling of hygiene. Most existing operating theatres in Germany do not correspond to the state of the art today. Many are around 30 years old. Investments in the future, out of place!
What is the always so elegantly and sloppily said standard saying of some surgeons about an operation?
Medicine meets technology - Only through planning we can reach this goal!
With new concepts, cleanroom technology is returning to its roots - the fight against germs in hospitals.
Thanks to better hygiene and lower energy consumption, healthcare costs are reduced
As biopharma searches for vaccines and treatments to alleviate the crisis, how can companies manage shortened timelines to rapidly develop and manufacture safe and effective products on a global scale? A recent Endpoints webinar sheds some light
New application study describes the separation and characterisation of adeno associated virus serotypes by AF4.
In a new application study, Postnova Analytics reports that its latest generation of Asymmetrical Flow Field Flow Fractionation (AF4) systems are providing labs worldwide with a uniquely powerful technique to characterize and quantitate virus and virus-like particles.
China is stepping up its efforts to produce and ship active pharmaceutical ingredients (APIs), with a focus on meeting international demand, particularly for those showing potential to treat the COVID-19 disease, according to Chinese officials on Tuesday
The Middle East and North Africa is the region that is earmarked for quick expansion of the pharmaceutical sector. According to research, the Pharmaceutical market has reached $25B in value in 2018, with a short-term growth of 13% from 2017 to 2018. This robust market is forecasted to grow to $60B by 2025.
A number of companies have extended their investments, with more to come in upcoming years
A number of global pharmaceutical enterprise representatives have said they are willing to expand their investments in Egypt, benefiting from Egypt’s location and potential as a regional hub for the MENA region.